SMIP34 is a PELP1 inhibitor. SMIP34 binds to PELP1 with a Kd of 37.4 µM. SMIP34 inhibits cancer cell proliferation and tumor progression. SMIP34 can be used for breast cancer research, and is active against wild-type (WT), mutant (MT) ER+ and therapy-resistant (TR)-ER+ breast cancer[1].
Molecular Weight:
486.01
Purity:
90
CAS Number:
[1189710-20-0]
Formula:
C25H32ClN5O3
Target:
Apoptosis
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
